Ufp Technologies (UFPT) Income from Continuing Operations (2010 - 2026)
Ufp Technologies' (UFPT) quarterly Income from Continuing Operations came in at $20.9 million in Q2 2026, up 21.37% on a YoY basis from $17.2 million in Q2 2025, and up 19.18% quarter-over-quarter from $17.5 million in Q1 2026.
Analysis
Ufp Technologies (UFPT) Income from Continuing Operations (2010 - 2026) Analysis & Trends
Ufp Technologies (UFPT) has reported Income from Continuing Operations for 17 consecutive years, with $20.9 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Income from Continuing Operations rose 21.37% year-over-year to $20.9 million; the trailing twelve-month figure through Jun 2026 stood at $72.3 million (up 7.74% YoY), and the FY2025 full-year result was $68.3 million, up 15.82% from the prior year.
- Income from Continuing Operations climbed to $20.9 million in Q2 2026 per UFPT's latest filing, from $17.5 million in the prior quarter.
- Across five years, Income from Continuing Operations topped out at $20.9 million in Q2 2026 and bottomed at $4.0 million in Q4 2022.
- Historically, Income from Continuing Operations has averaged $13.8 million across 5 years, with a median of $15.0 million in 2024.
- The sharpest annual moves came in 2022 and 2023: Income from Continuing Operations surged 415.7% in 2022, then plunged 40.15% in 2023.
- Over 5 years, Income from Continuing Operations stood at $4.0 million in 2022, then jumped by 191.59% to $11.6 million in 2023, then soared by 41.07% to $16.4 million in 2024, then gained by 7.27% to $17.6 million in 2025, then climbed by 18.7% to $20.9 million in 2026.
- According to Business Quant data, Income from Continuing Operations over the past three periods registered $20.9 million, $17.5 million, and $17.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 823.20 Mn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 1.48 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 1.28 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 905.00 Mn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 241.40 Mn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | -92.00 Mn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 249.10 Mn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Ufp Technologies | 2.15 Bn | 2.14 Bn | 50.92 Mn | 20.85 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 20.85 Mn |
| Mar 31, 2026 | 17.50 Mn |
| Dec 31, 2025 | 17.57 Mn |
| Sep 30, 2025 | 16.38 Mn |
| Jun 30, 2025 | 17.18 Mn |
| Mar 31, 2025 | 17.18 Mn |
| Dec 31, 2024 | 16.38 Mn |
| Sep 30, 2024 | 16.36 Mn |
| Jun 30, 2024 | 13.55 Mn |
| Mar 31, 2024 | 12.69 Mn |
| Dec 31, 2023 | 11.61 Mn |
| Sep 30, 2023 | 11.69 Mn |
| Jun 30, 2023 | 11.88 Mn |
| Mar 31, 2023 | 9.74 Mn |
| Dec 31, 2022 | 3.98 Mn |
| Sep 30, 2022 | 19.54 Mn |
| Jun 30, 2022 | 8.93 Mn |
| Mar 31, 2022 | 4.86 Mn |
| Dec 31, 2021 | 1.43 Mn |
| Sep 30, 2021 | 3.79 Mn |